Successful treatment of hidradenocarcinoma using ALA-PDT combined with local narrow margin excision.

Photodiagnosis Photodyn Ther

Institute of Photomedicine Shanghai Skin Disease Hospital School of Medicine, Tongji University, Shanghai 200443, China; Skin Cancer Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China. Electronic address:

Published: December 2023

AI Article Synopsis

  • Hidradenocarcinoma is a rare but aggressive skin cancer that often recurs and spreads, posing serious health risks.
  • Researchers have limited treatment options for this condition, making effective management challenging.
  • A successful case is reported where a combination of 5-aminolevulinic acid photodynamic therapy and local excision led to no recurrence of the cancer in an elderly woman after one year.

Article Abstract

Hidradenocarcinoma is a rare malignancy of sweat gland differentiation. It is known for its high rate of recurrence and metastasis, which has a serious impact on human health and aesthetics. However, the treatment options for this disease are limited, making prompt and appropriate treatment is a daunting challenge. In this report, we present the first successful cure of hidradenocarcinoma using 5-aminolevulinic acid photodynamic therapy (ALA-PDT) combined with local narrow margin excision on the left side of the forehead in an elderly woman. No recurrence during one year of follow-up after the combined therapy. This case will provide a valuable reference for more efficient management of similar cases in clinic.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pdpdt.2023.103791DOI Listing

Publication Analysis

Top Keywords

ala-pdt combined
8
combined local
8
local narrow
8
narrow margin
8
margin excision
8
successful treatment
4
treatment hidradenocarcinoma
4
hidradenocarcinoma ala-pdt
4
excision hidradenocarcinoma
4
hidradenocarcinoma rare
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!